Cargando…

Effects of bisoprolol in combination with trimetazidine on the treatment of heart failure and concomitant chronic obstructive pulmonary disease

OBJECTIVE: To evaluate the effects of bisoprolol combined with trimetazidine on the treatment of heart failure patients having concomitant chronic obstructive pulmonary disease (COPD); in comparison with control group treated with standard therapy only. METHODS: A total of 120 heart failure patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Yuanyuan, Xu, Dingli, Li, Minxiong, Wu, Zenglong, Huang, Yongpeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103135/ https://www.ncbi.nlm.nih.gov/pubmed/27882023 http://dx.doi.org/10.12669/pjms.325.10850

Ejemplares similares

Effects of trimetazidine in combination with bisoprolol in patients with chronic heart failure and concomitant chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Zhang, Xiaoyan, et al.
Publicado: (2021)

Bisoprolol in the treatment of chronic heart failure
por: de Groote, Pascal, et al.
Publicado: (2007)

Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease
por: Su, Vincent Yi-Fong, et al.
Publicado: (2016)

Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease: Erratum
Publicado: (2016)

Trimetazidine in Heart Failure
por: Shu, Hongyang, et al.
Publicado: (2021)

Is Treatment with Trimetazidine Beneficial in Patients with Chronic Heart Failure?
por: Zhou, Xiang, et al.
Publicado: (2014)

Trimetazidine and Bisoprolol to Treat Angina in Symptomatic Patients: Post Hoc Analysis From the CHOICE-2 Study
por: Glezer, Maria
Publicado: (2020)

Effects of ivabradine hydrochloride combined with trimetazidine on myocardial fibrosis in rats with chronic heart failure
por: Ma, Dongwen, et al.
Publicado: (2019)

Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results
por: Metra, Marco, et al.
Publicado: (2007)

Value of PTEN and Echocardiography in Predicting the Efficacy of Trimetazidine Combined with Metoprolol in the Treatment of Heart Failure
por: Feng, Xue-Hong, et al.
Publicado: (2021)

Impact of bisoprolol and amlodipine on cardiopulmonary responses and symptoms during exercise in patients with chronic obstructive pulmonary disease
por: Lan, Chou-Chin, et al.
Publicado: (2023)

Bisoprolol reverses down-regulation of potassium channel proteins in ventricular tissues of rabbits with heart failure()
por: Li, Xi, et al.
Publicado: (2011)

Effectiveness and Tolerability of Trimetazidine 80 Mg Once Daily in Patients with Stable Angina Uncontrolled with Bisoprolol-Based Therapy: The Modus Vivendi Observational Study
por: Lopatin, Yuri, et al.
Publicado: (2021)

Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK
por: Shu, Hongyang, et al.
Publicado: (2021)

Trimetazidine therapy for diabetic mouse hearts subjected to ex vivo acute heart failure
por: Breedt, Emilene, et al.
Publicado: (2017)

The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction
por: Choi, Ki Hong, et al.
Publicado: (2019)

Patients with heart failure and concomitant chronic obstructive pulmonary disease participating in the Heart Failure Pilot Survey (ESC-HF Pilot) – Polish population
por: Straburzyńska-Migaj, Ewa, et al.
Publicado: (2015)

Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study
por: Lee, Hae-Young, et al.
Publicado: (2016)

CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973]
por: Quiros, Franklin R, et al.
Publicado: (2006)

Protective Effect of Trimetazidine on Potassium Ion Homeostasis in Myocardial Tissue in Mice with Heart Failure
por: Yang, Kaijing, et al.
Publicado: (2022)

Trimetazidine combined with berberine on endothelial function of patients with coronary heart disease combined with primary hypertension
por: Zhang, Hui, et al.
Publicado: (2018)

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial
por: Düngen, Hans-Dirk, et al.
Publicado: (2011)

The Coexistence of Chronic Obstructive Pulmonary Disease and Heart Failure
por: Khalid, Khizer, et al.
Publicado: (2021)

Trimetazidine in heart failure with preserved ejection fraction: a randomized controlled cross‐over trial
por: van de Bovenkamp, Arno A., et al.
Publicado: (2023)

A Comparative Study to Investigate the Effects of Bisoprolol in Patients with Chronic Heart Failure and Hypertension When Switched from Tablets to Transdermal Patches
por: Sezai, Akira, et al.
Publicado: (2023)

The Influence of EGCG on the Pharmacokinetics and Pharmacodynamics of Bisoprolol and a New Method for Simultaneous Determination of EGCG and Bisoprolol in Rat Plasma
por: Zeng, Weiwei, et al.
Publicado: (2022)

Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)
por: Cotton, Seonaidh, et al.
Publicado: (2022)

Bisoprolol: Lack of efficacy: case report
Publicado: (2021)

The influence of edema on the bisoprolol blood concentration after bisoprolol dermal patch application: A case-control study
por: Takahashi, Yuji, et al.
Publicado: (2021)

Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients
por: Peters, Eva L., et al.
Publicado: (2021)

Neuroprotective effects of combined trimetazidine and progesterone on cerebral reperfusion injury
por: Dhote, Vipin, et al.
Publicado: (2022)

Economic evaluation of trimetazidine in the management of chronic stable angina in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2016)

Clinical Efficacy of Trimetazidine and Holistic Management in the Treatment of Coronary Heart Disease
por: QU, Li, et al.
Publicado: (2018)

Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
por: Lipworth, Brian, et al.
Publicado: (2016)

Mechanisms Underlying the Association of Chronic Obstructive Pulmonary Disease With Heart Failure
por: Lagan, Jakub, et al.
Publicado: (2021)

Bisoprolol and Bisoprolol-Valsartan Compatibility Studied by Differential Scanning Calorimetry, Nuclear Magnetic Resonance and X-Ray Powder Diffractometry
por: Skotnicki, Marcin, et al.
Publicado: (2014)

Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy
por: Imori, Yoichi, et al.
Publicado: (2019)

Defining the Role of Trimetazidine in the Treatment of Cardiovascular Disorders: Some Insights on Its Role in Heart Failure and Peripheral Artery Disease
por: Chrusciel, Piotr, et al.
Publicado: (2014)

Observation of Curative Effect of Trimetazidine Combined with Metoprolol in Elderly Patients with Coronary Heart Disease Complicated with Heart Failure and the Effect of Myocardial Remodeling by Integrated Traditional Chinese and Western Medicine
por: Lu, Yingyi, et al.
Publicado: (2022)

Effect of Enalapril Combined with Bisoprolol on Cardiac Function and Inflammatory Indexes in Patients with Acute Myocardial Infarction
por: Huang, Kaiyue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bin5g1k9j6bnobs956lq2ima2a